Sponsored by
This is the peer reviewed publication of the DCVAX trial that we have been waiting for! Same excellent results that we reported in May but they go into details such as how the external control arm was constructed to account for all of the variables including the fact that the DCVAX trial rejected patients who progressed quickly during radiation. I feel the article responds very well to every critisism I heard from the May report.. And it was published in a high impact Journal - JAMA Oncology which has an impact factor of 33, where anything over a 10 is considered "excellent"!